Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
- Health A-Z
- Diet & Fitness
- THS Health Summit
- Healthy Relationships
- Web Stories
- Women's Health
- Home remedies
Excessive use of certain commonly used antibiotics is linked to an increased risk of Parkinson's disease, a progressive nervous system disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination, says a study.
This connection may be explained by their disruptive effects on the gut microbial ecosystem, said the study published in the journal Movement Disorders.
The strongest associations were found for broad spectrum antibiotics and those that act against against anaerobic bacteria and fungi.
"The link between antibiotic exposure and Parkinson's disease fits the current view that in a significant proportion of patients the pathology of Parkinson's may originate in the gut, possibly related to microbial changes, years before the onset of typical Parkinson motor symptoms such as slowness, muscle stiffness and shaking of the extremities," said research team leader Filip Scheperjans from Helsinki University Hospital, Finland.
"It was known that the bacterial composition of the intestine in Parkinson's patients is abnormal, but the cause is unclear. Our results suggest that some commonly used antibiotics, which are known to strongly influence the gut microbiota, could be a predisposing factor," Scheperjans said.
In the gut, pathological changes typical of Parkinson's disease have been observed up to 20 years before diagnosis.
Constipation, irritable bowel syndrome and inflammatory bowel disease have been associated with a higher risk of developing Parkinson's disease.
Exposure to antibiotics has been shown to cause changes in the gut microbiome and their use is associated with an increased risk of several diseases, such as psychiatric disorders and Crohn's disease.
However, these diseases or increased susceptibility to infection do not explain the now observed relationship between antibiotics and Parkinson's.
The study compared antibiotic exposure during the years 1998-2014 in 13,976 Parkinson's disease patients and compared it with 40,697 non-affected persons matched for the age, sex and place of residence.
Antibiotic exposure was examined over three different time periods: 1-5, 5-10, and 10-15 years prior to the index date, based on oral antibiotic purchase data.
Exposure was classified based on number of purchased courses. Exposure was also examined by classifying antibiotics according to their chemical structure, antimicrobial spectrum, and mechanism of action.
"The discovery may also have implications for antibiotic prescribing practices in the future. In addition to the problem of antibiotic resistance, antimicrobial prescribing should also take into account their potentially long-lasting effects on the gut microbiome and the development of certain diseases," Scheperjans said.